NON SMALL CELL LUNG CANCER (STAGE III)
Clinical trials for NON SMALL CELL LUNG CANCER (STAGE III) explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG CANCER (STAGE III) trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG CANCER (STAGE III), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to keep early lung cancer from coming back
Disease control OngoingThis study tests whether adding the immunotherapy drug durvalumab to precise radiation therapy (SBRT) can better control early-stage non-small cell lung cancer compared to radiation alone. About 13 adults with stage I to IIIA lung cancer received the combination. The main goal is…
Matched conditions: NON SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:54 UTC
-
New pill may keep stage III lung cancer at bay after Chemo-Radiation
Disease control OngoingThis study tests whether taking osimertinib daily after standard chemoradiation can delay cancer growth in people with stage III EGFR-mutated non-small cell lung cancer that hasn't spread. About 216 adults with this specific genetic type of lung cancer will receive either osimert…
Matched conditions: NON SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 04:46 UTC
-
Blood test may predict lung cancer outcomes before surgery
Knowledge-focused OngoingThis study is looking at 100 people with stage IIIA non-small cell lung cancer who are getting treatment before surgery. Researchers want to see if a blood test that looks for tumor DNA (ctDNA) can help predict how well the treatment is working and how long patients stay cancer-f…
Matched conditions: NON SMALL CELL LUNG CANCER (STAGE III)
Sponsor: Fundación GECP • Aim: Knowledge-focused
Last updated May 26, 2026 04:48 UTC
-
Gut bacteria may hold key to lung cancer therapy outcomes
Knowledge-focused OngoingThis study looks at whether bacteria from throat swabs, stool, and lung samples can help predict which patients with stage III lung cancer will have their cancer return during immunotherapy (durvalumab) after chemoradiation. Researchers will also check if antibiotics affect treat…
Matched conditions: NON SMALL CELL LUNG CANCER (STAGE III)
Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC